Skip to content
Life Sciences Series C Founded 2017

HAGAR

Developer of a non-invasive glucometer device for diabetes patients. The company's device utilizes radiofrequency waves to continuously measure glucose levels in the blood. The device is integrated with a smartphone application to track glucose readings. The company was founded in 2017 and headquartered in Tel Aviv, Israel. It has raised $25M in series c funding. The company operates in the Life Sciences - Diabetes,…

📍 Tel Aviv, Israel · Diabetes,

Funding snapshot

Last roundSeries C
Amount$5M
Date11 August 2023
Total raised$25M

About

Developer of a non-invasive glucometer device for diabetes patients. The company's device utilizes radiofrequency waves to continuously measure glucose levels in the blood. The device is integrated with a smartphone application to track glucose readings. The company was founded in 2017 and headquartered in Tel Aviv, Israel. It has raised $25M in series c funding. The company operates in the Life Sciences - Diabetes, HealthTech - Disease Self Management, High Tech - Wearable Technology space. Its offerings span Diabetes - Medical Devices - Monitoring Device. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.

Business model

Wearable Technology > Health and Wellness Devices > Diabetes Monitoring,

Disease Self Management > Diabetes > Monitoring > Glucose > Device > Wearable,

Diabetes > Medical Devices > Monitoring Devices > CGM > Non-Invasive

Team background

College Wise > Tel Aviv University

Latest coverage

No articles yet.

Raising like HAGAR?

Analyze your pitch deck before your next raise.

Analyze My Deck →